Karen Hubbard to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Karen Hubbard has written about Xenograft Model Antitumor Assays.
Connection Strength
0.040
-
Elie BT, Hubbard K, Pechenyy Y, Layek B, Prabha S, Contel M. Preclinical evaluation of an unconventional ruthenium-gold-based chemotherapeutic: RANCE-1, in clear cell renal cell carcinoma. Cancer Med. 2019 08; 8(9):4304-4314.
Score: 0.040